那年夏天你去了哪里

7 killed as a suspected migrant-smuggling vehicle crashes in southern Germany_我的网站

A |     Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。    BERLIN -- A vehicle apparently packed with migrants left a highway in southern Germany at high speed on Friday and crashed as the driver tried to evade a police check, killing seven people and injuring 16, authorities said. The accident happened near Ampfing, east of Munich on the A94 highway, which leads to the Austrian border. The van left the road and overturned.Police described the van, which had 23 people on board, as “a suspected smuggler vehicle." They said prosecutors had opened a homicide investigation.Bavaria's top security official, state Interior Minister Joachim Herrmann, said that the dead included a young child. The injured were taken to nearby hospitals. The Austrian-registered van was designed to carry nine people, and it wouldn't have been possible for many of the people on board to use seat belts, German news agency dpa reported. Police said the vehicle was carrying Syrians and Turks, while the driver was a stateless man resident in Austria.“The inhuman behavior of the smuggler, who was injured in the accident and wanted to evade being stopped by the federal police just to save his own skin, makes one speechless,” Herrmann said.Germany has seen large numbers of migrants arriving in recent months. The A94 is known as a smuggling route and the site of the accident is about 50 kilometers (31 miles) from the border with Austria, through which many migrants transit en route to Germany.Herrmann, whose conservative party belongs to Germany's main opposition bloc, told dpa that Friday's incident shows “how important it is to further strengthen immediate border controls in order to stop smugglers already at the border.”。

Current article:http://5eu4o.roubutianquegumaigoubingdian.cyou/l7zr/fhwii.html

Published on:18:05:04